search
Back to results

PINS Stimulator System for Deep Brain Stimulation in Huntington's Disease

Primary Purpose

Huntington's Disease

Status
Unknown status
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Deep Brain Stimulation
Sponsored by
Beijing Pins Medical Co., Ltd
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Huntington's Disease

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. Subject clinically symptomatic and genetically confirmed Huntington Disease (number of CAG repeats>= 36)
  2. Moderate stage of the disease (UHDRS motor>= 30)
  3. Predominant movement disorder
  4. Compliance of the patient, stable cognition during a 6 months phase prior to inclusion (Mattis Dementia Rating Scales(MDS)>/= 120)
  5. Signed informed consent.

Exclusion Criteria:

  1. Patients with hearing impairment;
  2. Failures of important organs and in severe conditions;
  3. Be reluctant or disabled to receive neuropsychological assessments;
  4. Participate in other clinical trial;
  5. Has a life expectancy of < 1 year.
  6. The investigator and/or enrollment review committee, would preclude participation in the study.

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Experimental

    Sham Comparator

    Arm Label

    Deep Brain Stimulation

    Placebo

    Arm Description

    Stimulation is on.

    Stimulation is off.

    Outcomes

    Primary Outcome Measures

    Unified Huntington's Disease Rating Scale(UHDRS)

    Secondary Outcome Measures

    Full Information

    First Posted
    September 28, 2014
    Last Updated
    October 13, 2016
    Sponsor
    Beijing Pins Medical Co., Ltd
    Collaborators
    Beijing Tiantan Hospital
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT02263430
    Brief Title
    PINS Stimulator System for Deep Brain Stimulation in Huntington's Disease
    Official Title
    PINS Stimulator System for Deep Brain Stimulation in Huntington's Disease
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    August 2016
    Overall Recruitment Status
    Unknown status
    Study Start Date
    December 2016 (undefined)
    Primary Completion Date
    December 2018 (Anticipated)
    Study Completion Date
    December 2018 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Sponsor
    Name of the Sponsor
    Beijing Pins Medical Co., Ltd
    Collaborators
    Beijing Tiantan Hospital

    4. Oversight

    Data Monitoring Committee
    Yes

    5. Study Description

    Brief Summary
    Deep Brain Stimulation (DBS) of the Globus pallidus internus(GPi) is useful in the treatment of different forms of chorea, including Huntington's disease (HD).

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Huntington's Disease

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Not Applicable
    Interventional Study Model
    Parallel Assignment
    Masking
    ParticipantOutcomes Assessor
    Allocation
    Randomized
    Enrollment
    8 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    Deep Brain Stimulation
    Arm Type
    Experimental
    Arm Description
    Stimulation is on.
    Arm Title
    Placebo
    Arm Type
    Sham Comparator
    Arm Description
    Stimulation is off.
    Intervention Type
    Device
    Intervention Name(s)
    Deep Brain Stimulation
    Other Intervention Name(s)
    Rechargeable Neurostimulator
    Primary Outcome Measure Information:
    Title
    Unified Huntington's Disease Rating Scale(UHDRS)
    Time Frame
    12 month

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    18 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: Subject clinically symptomatic and genetically confirmed Huntington Disease (number of CAG repeats>= 36) Moderate stage of the disease (UHDRS motor>= 30) Predominant movement disorder Compliance of the patient, stable cognition during a 6 months phase prior to inclusion (Mattis Dementia Rating Scales(MDS)>/= 120) Signed informed consent. Exclusion Criteria: Patients with hearing impairment; Failures of important organs and in severe conditions; Be reluctant or disabled to receive neuropsychological assessments; Participate in other clinical trial; Has a life expectancy of < 1 year. The investigator and/or enrollment review committee, would preclude participation in the study.
    Central Contact Person:
    First Name & Middle Initial & Last Name or Official Title & Degree
    Jia Fumin, PhD
    Phone
    010-59361265
    Email
    pins_medical@163.com
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Li Luming, PhD
    Organizational Affiliation
    Tsinghua University
    Official's Role
    Study Chair

    12. IPD Sharing Statement

    Learn more about this trial

    PINS Stimulator System for Deep Brain Stimulation in Huntington's Disease

    We'll reach out to this number within 24 hrs